Trinity Biotech (TRIBY) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY)

TRIB 0.700

+0.4%

Jan 20 3:55 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: DMore who wrote (8468)	3/9/1998 9:49:00 PM
From: Keiko	Read Replies (1) of 14328

D'More, World Health Organization (WHO ) has classified H.Pylori as a Class 1 Carcinogen and it has been implicated as the causative agent in many Gastric Tumors. Trinity Biotech announced an agreement with Centocor ( CNTO ) to develope rapid tests using the Unigold platform and the CNTO serum tumor markers including the CA72-4tm ( gastrointestinal cancer ) and I quote: " These products are in-vitro diagnostic blood tests used by physicians to monitor the growth or disappearance of tumors before and after treatment and are selectively used by physicians to diagnose and monitor the development of cancers in patients. The current world-wide diagnostic markets for cancer markers is $400 million." (July 8, 1997)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next